A vaccine for the deadly Ebola virus is being processed in Frederick.
The vaccine is a joint product of the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. The active ingredients of the vaccine are sent to the Vaccine Pilot Plant on Geoffrey Way, where they are put into vials and prepared for use, according to NIAID.
NIAID spokeswoman Jennifer Routh said the vaccine is "solely being used in clinical trials" at the National Institutes of Health’s Clinical Center in Bethesda.
NIH started testing the vaccine on humans in September.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
active ingredients.. that's a obfuscating way of saying live ebola virus isn't it.
ReplyDeleteHuh?
ReplyDeleteHow about taking every infected person, loading them in a catapult, and fling them into Mexico, Canada or the ocean. Stop all flights to and from Africa, or anywhere near there.
ReplyDeleteI heard that this ebola medicine is derived from the tobacco plant.
ReplyDeleteI bet the Welfare CROWD Try and get it first.
ReplyDeleteSo here we have it. Create a panic so the pharmaceutical companies can reap the gain at our benefit and demise!
ReplyDeleteMost of the vaccine will be shipped to Africa so Obama's relatives can live!
ReplyDeleteanother vaccine huh? go figure. i wonder how many more viruses that america will create
ReplyDeleteGee GSK go figure!! This is a corporate scripted event unfolding. Just search "GSK Products" and prepare to be disgusted.
ReplyDelete